JPS6346700B2 - - Google Patents
Info
- Publication number
- JPS6346700B2 JPS6346700B2 JP56167749A JP16774981A JPS6346700B2 JP S6346700 B2 JPS6346700 B2 JP S6346700B2 JP 56167749 A JP56167749 A JP 56167749A JP 16774981 A JP16774981 A JP 16774981A JP S6346700 B2 JPS6346700 B2 JP S6346700B2
- Authority
- JP
- Japan
- Prior art keywords
- water
- nylon
- sheet
- soluble
- affected area
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229920001778 nylon Polymers 0.000 claims description 41
- 239000004677 Nylon Substances 0.000 claims description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 239000000126 substance Substances 0.000 claims description 22
- 239000000203 mixture Substances 0.000 claims description 17
- 229920005989 resin Polymers 0.000 claims description 16
- 239000011347 resin Substances 0.000 claims description 16
- 108010010803 Gelatin Proteins 0.000 claims description 7
- 239000008273 gelatin Substances 0.000 claims description 7
- 229920000159 gelatin Polymers 0.000 claims description 7
- 235000019322 gelatine Nutrition 0.000 claims description 7
- 235000011852 gelatine desserts Nutrition 0.000 claims description 7
- 229920001817 Agar Polymers 0.000 claims description 4
- 239000008272 agar Substances 0.000 claims description 4
- 229920001059 synthetic polymer Polymers 0.000 claims description 4
- 230000002209 hydrophobic effect Effects 0.000 claims description 3
- 238000010559 graft polymerization reaction Methods 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 241000894006 Bacteria Species 0.000 description 12
- 210000001124 body fluid Anatomy 0.000 description 12
- 239000010839 body fluid Substances 0.000 description 12
- 230000035699 permeability Effects 0.000 description 12
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 9
- 230000000844 anti-bacterial effect Effects 0.000 description 9
- 230000004888 barrier function Effects 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 229920001577 copolymer Polymers 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 229920000577 Nylon 6/66 Polymers 0.000 description 6
- TZYHIGCKINZLPD-UHFFFAOYSA-N azepan-2-one;hexane-1,6-diamine;hexanedioic acid Chemical compound NCCCCCCN.O=C1CCCCCN1.OC(=O)CCCCC(O)=O TZYHIGCKINZLPD-UHFFFAOYSA-N 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 239000004745 nonwoven fabric Substances 0.000 description 6
- 229920002085 Dialdehyde starch Polymers 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000002861 polymer material Substances 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 229920002292 Nylon 6 Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 208000028990 Skin injury Diseases 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 2
- 229920000571 Nylon 11 Polymers 0.000 description 2
- 229920000299 Nylon 12 Polymers 0.000 description 2
- 229920000305 Nylon 6,10 Polymers 0.000 description 2
- 229920000572 Nylon 6/12 Polymers 0.000 description 2
- 241000282320 Panthera leo Species 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 2
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 1
- CKPOABDCSSXDCY-UHFFFAOYSA-N 2-propan-2-yltetradecanoic acid Chemical compound CCCCCCCCCCCCC(C(C)C)C(O)=O CKPOABDCSSXDCY-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- 229920001605 Dextranomer Polymers 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229920001410 Microfiber Polymers 0.000 description 1
- 235000003805 Musa ABB Group Nutrition 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- DJDFFEBSKJCGHC-UHFFFAOYSA-N Naphazoline Chemical compound Cl.C=1C=CC2=CC=CC=C2C=1CC1=NCCN1 DJDFFEBSKJCGHC-UHFFFAOYSA-N 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 229920002302 Nylon 6,6 Polymers 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 235000015266 Plantago major Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241001104043 Syringa Species 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- BXKDSDJJOVIHMX-UHFFFAOYSA-N edrophonium chloride Chemical compound [Cl-].CC[N+](C)(C)C1=CC=CC(O)=C1 BXKDSDJJOVIHMX-UHFFFAOYSA-N 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- CYKDLUMZOVATFT-UHFFFAOYSA-N ethenyl acetate;prop-2-enoic acid Chemical compound OC(=O)C=C.CC(=O)OC=C CYKDLUMZOVATFT-UHFFFAOYSA-N 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 239000003658 microfiber Substances 0.000 description 1
- 229960004760 naphazoline hydrochloride Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001521 polyalkylene glycol ether Polymers 0.000 description 1
- 229920006122 polyamide resin Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 102220101420 rs876658520 Human genes 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 1
- 229940034107 sulfazine Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Description
本発明は特に切傷、湿疹、火傷、潰瘍等の患部
の保護及び治療に好適に用いられる外皮用組成物
に関する。
従来、切傷、湿疹、火傷、潰瘍等に対しては、
その患部をガーゼ、不織布、油紙等で覆つて保護
したり、或いは膏薬をガーゼ、不織布等に塗布
し、患部にあてるなどの処置を施していた。
しかし、ガーゼや不織布は、外気中の細菌等に
対しては何らバリヤー性を有さず、また患部から
浸出する血液等の体液の吸収量が少なく、更に浸
出した体液が固化するときに患部にガーゼや不織
布が固着し、ガーゼや不織布を除去する際に苦痛
が伴なつたり、せつかく治癒した患部を再び傷つ
け、治療効果を遅らせる等の欠点があり、またガ
ーゼや不織布は伸縮性が少なく、異和感が強いと
いう問題もあつた。また、油紙は水蒸気透過性が
悪く、患部をむらすなどの問題があり、かえつて
患部を悪化させる場合が多いものであつた。
このため、ゼラチンゲルやミクロフアイバー、
或いはデブリサン(商品名)で知られる体液吸収
性の微粉体を用いる治療法も行なわれているが、
これらは療法及び取扱いが極めて煩雑で、熟達し
た専門医でなければ充分に治療効果が発揮されな
い等の問題があつた。
更に最近では、患部に対する処置を簡便化し、
かつガスや水分の交換性と菌バリヤー性との相反
する機能を持たせることを目的とし、不織布やプ
ラスチツクフイルムを組合せたり、加工すること
によつて得られる医療用シートも提案されている
が、効果の点や製造法、薬物等の配合性の点で必
ずしも十分なものではない。
本発明者は上記欠点を解決するため鋭意研究を
行なつた結果、ナイロン樹脂に吸水性高分子物質
を配合することによつて得られる膜状物が水蒸気
透過性に優れていると共に、菌バリヤー性に優
れ、しかも体液吸収能力も高く、また薬物を配合
した場合には薬物の保持力、放出性も良好であつ
て、出血や滲出性皮膚傷害に対し有効に適用し
得、更に簡便に使用し得ると共に、その製造も簡
単になされ得ることを見い出し、本発明をなすに
至つたものである。
以下、本発明につき詳しく説明する。
本発明に係る外皮用組成物は、ナイロン樹脂と
吸水性高分子物質とを含有するもので、特に切
傷、湿疹、火傷、潰瘍等の出血や滲出性皮膚傷害
に対し好適に適用されるものであり、シート状或
いは患部に塗布して被膜を形成させる液状等の形
態に調製され得る。
本発明において、ナイロン樹脂としては、ナイ
ロン6、ナイロン66、ナイロン610、ナイロン11、
ナイロン12等の一般の全てのナイロン樹脂(ポリ
アミド樹脂)が使用可能であるが、特に組成物製
造性の簡便な点及び形成される被膜の水分透過性
が高い点からアルコール可溶性ナイロンを用いる
ことがより好ましい。
この場合、アルコール可溶性ナイロンとして
は、共重合タイプ、変性ナイロン、共重合―変性
ナイロン等がある。共重合タイプのナイロンとし
ては、ナイロン6/66/610、ナイロン6/66/
12、ナイロン6/69/12、ナイロン6/612/12、
ナイロン6/66/69/12、ナイロン6/66/11/
12、ナイロン6/66/612/12、ナイロン6/
66/ビス(4―アミノシクロヘキシル)メタン―
6等の3元或いはそれ以上の共重合体が挙げら
れ、具体的には東レ社製CM―4000、CM―4001、
CM―8000、ジユポン社製ザイテル―61,63,
69、BASF社製ウルトラアミド1A、1C、5A、
6A、10、ダイセル社製ダイアミド等が用いられ
得る。また、変性ナイロンは6―ナイロンのα位
の水素をジメチルアミノ基で置換したものやアミ
ド基の水素をアルコキシアル基等で置換したもの
で、帝国化学産業社製トレジンF30、F30C、
F30X等が使用され得、共重合―変性ナイロンは
共重合タイプのものと変性タイプのものとを組合
せたもので、ダイセル社製のダイアミドXシーズ
のもの等が使用され得る。なお、上に例示したナ
イロンはいずれも融点が80〜160℃の範囲にある
ものである。
本発明においては、上記ナイロンはその1種を
単独で使用しても2種以上を組合せて用いるよう
にしてもよい。またアルコール可溶性ナイロンを
用いて組成物を液状の形態に調製する場合、その
配合量は特に制限されないが、組成物全体の1〜
20%(重量%、以下同じ)とすることが好まし
い。ナイロン配合量が少なすぎると1回の塗布に
より形成される被膜が薄すぎる場合が生じ、また
ナイロン配合量が多すぎると組成物が高粘度とな
り、溶解作業性及び使用性が劣る場合が生ずる。
また、吸水性高分子物質としては、水には膨
潤、分散するも実質的には水と不溶のものが使用
し得、例えばゼラチン、寒天、車前草(オオバ
コ)の被殻であるシヤゼンシ、それにゼラチン―
金属塩(アルミニウム明ばん等)架橋体やゼラチ
ン―アルデヒド化合物(ジアルデヒドデンプン、
ホルムアルデヒド)架橋体などのゼラチン架橋体
等が好適に用いられ、更に合成水溶性物質の架橋
体、グラフト重合によつて水溶性幹高分子物質に
他の水溶性高分子物質を導入したもの、親水セグ
メントと疎水性セグメントを有する合成重合体等
の親水性合成高分子吸水性樹脂を用いられ得る。
親水性合成高分子吸水性樹脂としては、デンプン
アクリロニトリルグラフト重合体及びそのケン化
物、デンプンとアクリル酸又はその塩との共重合
体架橋物、酢酸ビニル―アクリル酸エステル共重
合体のケン化物、アクリロニトリル系共重合体の
加水分解物、アクリルアミド系重合体の加水分解
物、アクリル酸又はその塩の架橋体等が挙げら
れ、具体的には市販品として三洋化成社製サンウ
エツトIM―300、花王社製ワンダージエル、住友
化学社製ハイドロゲルS―50、日本触媒社製アク
アリツクCA、昭和電工社製PX、ジエネラルミル
ズ社製SGP、エクスラン社製FX等が使用され得
る。
なお、これら吸水性高分子物質はその1種を単
独で用いても2種以上を組合せて用いてもよい。
また、吸水性高分子物質は粉粒状であつても繊維
状であつてもよく、その大きさは特に限定される
ものではないが、粉粒状の場合は150メツシユ又
はそれより細かいものが好ましく、繊維状の場合
には直径10μ以下、長さ1mm以下のものが好まし
く、このようにサイズが小さい程被膜にした場合
の均一性及び吸水性能を向上させる。
前記吸水性高分子物質の配合量は必ずしも制限
されないが、ナイロン樹脂量に対して0.05〜300
%とすることが好ましく、吸水性高分子物質量が
少なすぎると充分にその効果を達し得ず、多すぎ
るとシート状に形成するときにナイロンが充分に
連続層とはなり得ず、従つて膜強度が低下した
り、柔軟性が低下したり、細孔が生じたりする場
合がある。
本発明には、上記成分に加えて、必要により吸
水速度、水蒸気透過性、被膜物性等を調整する目
的で、他の高分子化合物、例えばポリビニルピロ
リドン、ポリビニルピロリドン/ビニルアセテー
ト共重合体、メチルビニルエーテル/無水マレイ
ン酸共重合体、ポリアクリル酸エステル類、ポリ
アクリル酸/塩、カルボキビニルポリマー、それ
に親水性ウレタンプレポリマー等をナイロン樹脂
量に対して0〜30%配合することができる。
この場合、親水性ウレタンプレポリマーは特に
ナイロン被膜を柔軟にし、かつ引張り強度等の機
械的強度を向上させると共に、水分透過性を改良
し、ナイロン被膜の経時安定性をも増大させるの
で有効である。親水性ウレタンプレポリマーはナ
イロン樹脂に対し可塑剤的な効果を有すると共
に、単に可塑剤としての効果のみにとどまらず、
被膜強度を増大させる効果、剥離性能を向上させ
る剥離剤として効果を持つなど、ナイロン樹脂に
対して非常に優れた特性を付与する。
この親水性ウレタンプレポリマーとしては、2
価以上の多価アルコールとエチレンオキサイド又
は炭素数3以上のアルキレンオキサイドの1種又
は2種以上との付加反応による重合体又はランダ
ム共重合体(分子量500〜2000)である直鎖又は
分枝状のポリアルキレングリコール又はポリエー
テルポリオールと、2価以上のイソシアネート基
を有する化合物との反応によつて得られる分子末
端或いは分子鎖中に2個以上のイソシアネート基
を有するウレタンプレポリマーが好適に使用し
得、具体的には東邦化学工業社製ハイセルOH―
1A、ライオン社製UP―200等が用いられ得る。
なお、上記ウレタンプレポリマーはその1種を
単独で使用しても2種以上を併用するようにして
もよい。また、ウレタンプレポリマーの配合量は
必ずしも限定されないが、ナイロン樹脂に対して
0.5〜25%とすることが好ましく、ウレタンプレ
ポリマーの配合量が少なすぎるとその効果が十分
発揮されない場合が生じ、多すぎるとナイロン被
膜の引張り強度を低下させる場合が生じる。
本発明に係る外皮用組成物は、特に出血、浸出
性皮膚障害に好適に用いられるものであるが、こ
の場合細菌等に対するバリヤー性、抗菌性及び積
極的な治療効果を付与するために、更に殺菌剤、
抗炎症剤、抗生物質、組織修復剤等の薬物の1種
又は2種以上をナイロン樹脂に対して0〜30%配
合することもできる。
更に、これら薬物のシートからの放出性、経皮
吸収性をコントロールするために、プロピレング
リコール、ポリエチレングリコール、グリセリン
等の多価アルコール、イソプロピルミリスチン酸
等のエステル類、ラノリン、ワセリン等の油類、
ロウ類及び界面活性剤を配合することもできる。
その配合量は特に制限はないが、組成物をシート
状に形成した場合、そのシート状物中に0〜20%
含有するように配合し得る。
また、本発明の外皮用組成物は、上述したよう
にシート状に形成し、或いは皮膚上に被膜を形成
し得る液状に調製し得るものであるが、液状にす
る場合はその溶剤としてナイロン樹脂を溶解させ
るものであればいずれのものでも使用し得る。し
かし、特にエタノール、プロパノール、イソプロ
パノール等の低級アルコール及びこれら低級アル
コールと水との混合溶剤が好ましく使用され得
る。なお、低級アルコールと水との混合溶剤を用
いる場合、その比率は重量比として95:5〜60:
40とすることが好ましい。
本発明の外皮用組成物の製造法には特に制限は
なく、例えば液状の形態とする場合はナイロン樹
脂を適当な溶剤に溶解し、これに吸水性高分子物
質、更に必要により所望の成分を加えることによ
つて調製し得、またシート状に形成する場合はこ
の液状物をフローコーター等でシート状に塗布
し、溶剤を揮散、乾燥させたり、ナイロン樹脂を
熱融解し、これに吸水性高分子物質、その他の所
望成分を混入し、練合した後、シート状に成形す
る等の方法が採用し得る。
而して、本発明に係る外皮用組成物は、ナイロ
ン樹脂に吸水性高分子物質を配合することによ
り、その被膜は吸水性が非常に良好で、汗、血液
等の体液を迅速にしかも大量に吸収し得ると共
に、水分透過性に優れ、円滑に水分を外気中に放
散させることができ、患部をむらす等の不都合な
く使用し得、しかも細菌等に対するバリヤー性も
良好で、患部を良好に保護し得るものである。更
に、被膜の柔軟性、強度も高い上、体液による患
部とを固着も生ぜず、使用後の剥離除去の際も患
部を傷つけることなく容易に除去し得るものであ
る。また、薬物を保持させた場合には、薬物の保
持力、放出性が良好であり、更に本発明組成物は
簡便に使用し得ると共に、製造性も良好なもので
ある。
このように、吸水性高分子物質を配合したナイ
ロン被膜は、実際に適用した場合、患部をむらす
ことなく外的な物理的刺激や雑菌の侵入を長時間
に亘つて防ぎ、かつ浸出せる体液を患部より素速
く、大量に排除し、新生組織の形成を促進させる
ことができ、更に使用後の剥離除去も患部を傷つ
けることが殆んどなく、従つて切傷、火傷等の滲
出性皮膚疾患などに有効に使用し得るものであ
る。
以下、実施例を示し、本発明を具体的に説明す
るが、本発明は下記の実施例に限定されるもので
はない。
〔実施例 1〕
可溶性ナイロン(BASF社製ウルトラアミド
1C)の20%溶液(溶剤:エタノール/水90/
10重量比) 100g
吸水性高分子物質(日本触媒社製アクアリツク
CA) 2g
カルボキシビニルポリマー 0.3g
可溶性ナイロン溶液に吸水性高分子物質及びカ
ルボキシビニルポリマーを加え、これをシート状
に塗布し、乾燥して厚さ50μのシートを成形し
た。このシートは適当なサイズに切断し、粘着テ
ープで所定患部に貼り付けるか、シートの一面周
辺部に粘着剤を塗布し、患部に貼り付けることに
よつて使用し得る。また、患部をアルコールでぬ
らして貼り付けることにより、粘着剤を全く使用
しなくとも良好に接着する。
上記処方のシートは、後述する実験の結果から
も明らかなように、水蒸気透過性、体液吸収性、
菌バリヤー性、剥離性に優れ、かつ柔軟性、強度
にも優れ、患部の保護に好適なものであつた。
〔実施例 2〕
可溶性ナイロン(帝国化学社製トレジンF30)
の20%溶液(溶剤:エタノール/水 85/15重
量比) 20g
可溶性ナイロン(ウルトラアミド1C)の20%
溶液(溶剤:エタノール/水 90/10重量比)
80g
吸水性高分子物質(ゼラチン―ジアルデヒドデ
ンプン架橋体) 8g
吸水性高分子物質(アクアリツクCA) 2g
親水性ウレタンプレポリマー(ライオン社製
UP―200) 1.5g
以上の成分より実施例1と同様にして50μのシ
ートを成形した。
このものは、実施例1のシートの特長に加え、
更に柔軟性に富んだものとなり、関節部等の動き
に対しても充分なる追従性を示した。
〔実施例 3〕
塩化ベンザルコニウム 0.01g
グルコン酸クロルヘキシジン 0.01g
ジフエンヒドラミン 0.1g
塩酸ナフアゾリン 0.1g
可溶性ナイロン(ウルトラアミド1C)の20%
溶液(溶剤:エタノール/水 85/15重量比)
100.0g
吸水性高分子物質(シヤゼンシ) 10.0g
ポリビニルピロリドン(K―90) 0.5g
以上の成分より実施例1と同様にして50μのシ
ートを成形した。
このものは、抗菌性にも優れ、傷面、浸出性皮
療傷害治療用シートとして非常に有効性の高いも
のであり、除去の際も傷口を痛めることなく剥離
することができた。
〔実施例 4〕
スルフアジン 1.0g
グルコン酸クロルヘキシジン 0.01g
アラントイン 0.5g
可溶性ナイロン(ウルトラアミド1C)の20%
溶液(溶剤:エタノール/水 85/15重量比)
100.0g
吸水性高分子物質(ゼラチン―ジアルデヒドデ
ンプン架橋体) 15.0g
以上の成分より実施例1と同様にして50μのシ
ートを成形した。
このものは、びらん面を有する火傷及び潰瘍面
に極めて有効であり、表皮形成が促進され、かつ
使用後も新生組織を傷つけることなくスムーズに
除去されるものであるる。
なお、上記実施例において、ゼラチン―ジアル
デヒドデンプン架橋体としては、ゼラチンの10%
水溶液100gにジアルデヒドデンプン1gを加え、
加熱反応させたゲル状生成物を乾燥後粉砕するこ
とによつて得られたものを用いた。
次に、上記実施例で得られたシートにつき、そ
の水蒸気透過性、体液吸収量、剥離力、菌バリヤ
ー性、抗菌性を下記の方法により調べた。また比
較のため、可溶性ナイロン(ウルトラアミド1C)
のみを用いて得られる50μのナイロンシート及び
ガーゼについてもこれらの特性を調べた。
(1) 水蒸気透過性
半径17mmの円筒カツプ(ガラス製)中に水を
10g入れ、このカツプの口を種々のサンプルのシ
ートで密封し、37℃−65%、37℃−42%恒温恒湿
器に24時間放置した後、水分減量を測定し、その
値をシート1m2当りに換算し、これを水蒸気透過
性の指標とした。
(2) 体液吸収量
10cm×10cmのシートを生理食塩水中に5分間浸
した後取り出し、紙にはさんで余分の水分を除
いた後、増加量を測定し、これをシート1g当り
に換算し、体液吸収量とした。
(3) 剥離力
タバコフイルターを代用体液として作成した37
℃の10%ゼラチン―1%ポリビニルピロリドン溶
液中に浸して充分ふくませ、これを直ちにサンプ
ルシート上に置き、完全に乾燥させた後、テンシ
ロンメーターで2cm/分の速さで引きはがす時の
力を剥離性の指標とした。なお、シートは引きは
がし時の伸びを防止するため、測定時にシート背
部にセロテープを付した。
(4) シートの菌バリヤー性
寒天平板(細菌はSCD、酵母GP)にシートを
のせる。これに供試菌液に1分間浸したペーパー
デイスク(東洋製作社製)をのせ、1時間、24時
間放置後デイスクとシートを取り除き、培養する
(細菌37℃、24〜48時間;酵母27℃、6日間)。培
養後、これらの菌の発育の有無を肉眼的に判定す
る。
評価基準
+:菌透過
−:菌非透過
(5) シートの抗菌性
50℃に加温した滅菌寒天培地(細菌はSCD,
酵母はGP)に供試菌液を0.1ml/培地100mlにな
るように接種し、よく混合後、滅菌シヤーレに15
〜20ml分注し、凝固する。この平板にシートをの
せ、培養する(条件は(4)と同じ)。培養後これら
の阻止帯の幅を測定して抗菌性を判定する。
評価基準
−:抗菌性無、阻止帯の幅1mm以下
±:抗菌性有、 1〜3mm
+: 〃 、 3〜5mm
: 〃 、 5mm以上
なお、上記(4)及び(5)の実験において、供試菌と
しては下記のものを使用した。
細 菌
グラム陽性菌 黄色ブドウ球菌(St1)
グラム陰性菌 大腸菌 (E−Coli)
〃 緑膿菌 (Ps)
酵 母
カンジタ(Ca)
以上の結果を第1表〜第3表に示す。
The present invention particularly relates to a skin composition suitable for use in protecting and treating affected areas such as cuts, eczema, burns, and ulcers. Conventionally, for cuts, eczema, burns, ulcers, etc.
Treatments include covering the affected area with gauze, non-woven fabric, oiled paper, etc. to protect it, or applying ointment to gauze, non-woven fabric, etc. and applying it to the affected area. However, gauze and nonwoven fabrics do not have any barrier properties against bacteria in the outside air, and they also absorb only a small amount of body fluids such as blood that seep out from the affected area. There are drawbacks such as gauze and non-woven fabrics sticking to each other, causing pain when removing them, and re-injuring the affected area that has been painstakingly healed, delaying the therapeutic effect.Also, gauze and non-woven fabrics have little elasticity. There was also the issue of a strong sense of discomfort. In addition, oil paper has poor water vapor permeability and has the problem of staining the affected area, often making the affected area worse. For this reason, gelatin gels, microfibers,
Alternatively, there is a treatment method using a body fluid-absorbing fine powder known as Debrisan (trade name), but
These treatments are extremely complicated to treat and handle, and there are problems in that only a skilled specialist will be able to fully demonstrate their therapeutic effects. Furthermore, recently, treatments for the affected area have been simplified,
Medical sheets obtained by combining and processing nonwoven fabrics and plastic films have also been proposed, with the aim of providing contradictory functions of gas and moisture exchangeability and bacterial barrier properties. They are not necessarily sufficient in terms of effectiveness, manufacturing method, and compatibility with drugs, etc. The inventors of the present invention have conducted extensive research to solve the above-mentioned drawbacks, and have found that a film-like material obtained by blending a water-absorbing polymer substance with nylon resin has excellent water vapor permeability and is a bacterial barrier. It has excellent properties and has a high ability to absorb body fluids, and when combined with drugs, has good drug retention and release properties.It can be effectively applied to bleeding and exudative skin injuries, and is easy to use. The inventors have discovered that it is possible to manufacture the same, and that it can be easily manufactured, leading to the present invention. The present invention will be explained in detail below. The skin composition of the present invention contains a nylon resin and a water-absorbing polymeric substance, and is particularly suitable for use against bleeding and exudative skin injuries such as cuts, eczema, burns, and ulcers. It can be prepared in the form of a sheet or a liquid that can be applied to the affected area to form a film. In the present invention, nylon resins include nylon 6, nylon 66, nylon 610, nylon 11,
All general nylon resins (polyamide resins) such as nylon 12 can be used, but alcohol-soluble nylon is particularly preferred because it is easy to manufacture the composition and the formed film has high water permeability. More preferred. In this case, the alcohol-soluble nylon includes copolymer type, modified nylon, copolymer-modified nylon, and the like. Copolymer type nylons include nylon 6/66/610, nylon 6/66/
12, nylon 6/69/12, nylon 6/612/12,
Nylon 6/66/69/12, Nylon 6/66/11/
12, nylon 6/66/612/12, nylon 6/
66/Bis(4-aminocyclohexyl)methane-
Examples include ternary or higher copolymers such as CM-4000, CM-4001, manufactured by Toray Industries, Inc.
CM-8000, Zytel-61, 63, made by Ziupon
69, BASF Ultraamide 1A, 1C, 5A,
6A, 10, Daicel's Diamid, etc. may be used. In addition, modified nylons are those in which the hydrogen at the α position of 6-nylon is replaced with a dimethylamino group, or the hydrogen in the amide group is replaced with an alkoxyal group, etc., such as Torezin F30, F30C, manufactured by Teikoku Kagaku Sangyo Co., Ltd.
F30X, etc. may be used, and the copolymerized-modified nylon is a combination of a copolymerized type and a modified type, such as Diamid X Seeds manufactured by Daicel Corporation. Note that the nylons exemplified above all have melting points in the range of 80 to 160°C. In the present invention, the above-mentioned nylons may be used singly or in combination of two or more. In addition, when preparing a composition in a liquid form using alcohol-soluble nylon, the amount added is not particularly limited;
It is preferable to set it to 20% (weight%, the same applies hereinafter). If the amount of nylon blended is too small, the film formed by one application may be too thin, and if the amount of nylon blended is too large, the composition may have a high viscosity, resulting in poor dissolution workability and usability. Furthermore, as water-absorbing polymeric substances, those that swell and disperse in water but are essentially insoluble in water can be used, such as gelatin, agar, syringa, which is the shell of the plantain grass, and gelatin. ―
Cross-linked metal salts (aluminum alum, etc.) and gelatin-aldehyde compounds (dialdehyde starch,
Formaldehyde) crosslinked products such as gelatin crosslinked products are preferably used, and furthermore, crosslinked products of synthetic water-soluble substances, products in which other water-soluble polymer substances are introduced into water-soluble main polymer substances by graft polymerization, and hydrophilic A hydrophilic synthetic polymer water-absorbing resin such as a synthetic polymer having a segment and a hydrophobic segment may be used.
Examples of hydrophilic synthetic polymer water-absorbing resins include starch-acrylonitrile graft polymers and saponified products thereof, crosslinked copolymers of starch and acrylic acid or its salts, saponified products of vinyl acetate-acrylic acid ester copolymers, and acrylonitrile Examples include hydrolysates of copolymers, hydrolysates of acrylamide polymers, and crosslinked products of acrylic acid or its salts.Specifically, commercially available products include Sunwet IM-300 manufactured by Sanyo Chemical Co., Ltd. and Sunwet IM-300 manufactured by Kao Corporation. Wondergel, Hydrogel S-50 manufactured by Sumitomo Chemical, Aquaric CA manufactured by Nippon Shokubai, PX manufactured by Showa Denko, SGP manufactured by General Mills, FX manufactured by Exlan, etc. may be used. Note that these water-absorbing polymeric substances may be used alone or in combination of two or more.
Further, the water-absorbing polymeric substance may be in the form of powder or granules, and its size is not particularly limited, but if it is in the form of powder or granules, it is preferably 150 mesh or finer; In the case of a fibrous material, it is preferable to have a diameter of 10 μm or less and a length of 1 mm or less, and the smaller the size, the better the uniformity and water absorption performance when formed into a film. The blending amount of the water-absorbing polymeric substance is not necessarily limited, but is 0.05 to 300% based on the amount of nylon resin.
%. If the amount of the water-absorbing polymer substance is too small, the effect cannot be achieved sufficiently, and if it is too large, the nylon cannot form a continuous layer when formed into a sheet, and therefore Membrane strength may decrease, flexibility may decrease, and pores may occur. In addition to the above-mentioned components, the present invention includes other polymeric compounds such as polyvinylpyrrolidone, polyvinylpyrrolidone/vinyl acetate copolymer, methyl vinyl ether, etc., for the purpose of adjusting water absorption rate, water vapor permeability, film properties, etc., if necessary. /Maleic anhydride copolymer, polyacrylic ester, polyacrylic acid/salt, carboxyvinyl polymer, hydrophilic urethane prepolymer, etc. can be blended in an amount of 0 to 30% based on the amount of nylon resin. In this case, the hydrophilic urethane prepolymer is particularly effective because it makes the nylon coating flexible, improves mechanical strength such as tensile strength, improves water permeability, and increases the stability of the nylon coating over time. . Hydrophilic urethane prepolymer has a plasticizer-like effect on nylon resin, and is not only effective as a plasticizer.
It imparts excellent properties to nylon resin, such as increasing film strength and acting as a release agent to improve peeling performance. As this hydrophilic urethane prepolymer, 2
A linear or branched polymer or random copolymer (molecular weight 500 to 2000) produced by an addition reaction between a polyhydric alcohol with a higher valence or higher and one or more types of ethylene oxide or alkylene oxide having 3 or more carbon atoms. A urethane prepolymer having two or more isocyanate groups at the molecular end or in the molecular chain obtained by reacting a polyalkylene glycol or polyether polyol with a compound having two or more isocyanate groups is preferably used. Specifically, Hycel OH made by Toho Chemical Industry Co., Ltd.
1A, UP-200 manufactured by Lion Corporation, etc. can be used. In addition, the above-mentioned urethane prepolymers may be used alone or in combination of two or more. In addition, the amount of urethane prepolymer blended is not necessarily limited, but
The amount is preferably 0.5 to 25%; if the amount of the urethane prepolymer is too small, the effect may not be sufficiently exhibited, and if it is too large, the tensile strength of the nylon coating may be reduced. The skin composition according to the present invention is particularly suitable for use in bleeding and exudative skin disorders, but in this case, in order to impart barrier properties against bacteria, antibacterial properties, and active therapeutic effects, Fungicide,
One or more types of drugs such as anti-inflammatory agents, antibiotics, tissue repair agents, etc. can also be blended in an amount of 0 to 30% based on the nylon resin. Furthermore, in order to control the release properties and percutaneous absorption of these drugs from the sheet, polyhydric alcohols such as propylene glycol, polyethylene glycol, and glycerin, esters such as isopropyl myristic acid, oils such as lanolin and petrolatum,
Waxes and surfactants can also be blended.
There is no particular restriction on the amount of the compound, but when the composition is formed into a sheet, 0 to 20% of the amount is contained in the sheet.
It can be formulated to contain. In addition, the skin composition of the present invention can be formed into a sheet shape as described above, or can be prepared into a liquid form that can form a film on the skin. Any material can be used as long as it dissolves the . However, lower alcohols such as ethanol, propanol, and isopropanol, and mixed solvents of these lower alcohols and water can be preferably used. In addition, when using a mixed solvent of lower alcohol and water, the ratio is 95:5 to 60: by weight.
It is preferable to set it to 40. There are no particular restrictions on the method for producing the skin composition of the present invention. For example, when preparing a liquid form, nylon resin is dissolved in a suitable solvent, and a water-absorbing polymer substance and, if necessary, desired ingredients are added thereto. When forming a sheet, the liquid can be applied to a sheet using a flow coater, the solvent is volatilized, and the nylon resin is dried. A method may be adopted in which a polymeric substance and other desired components are mixed, kneaded, and then formed into a sheet. Therefore, the skin composition according to the present invention has a coating film that has very good water absorption properties by blending a water-absorbing polymer substance with a nylon resin, and can quickly remove body fluids such as sweat and blood in large quantities. In addition to being able to absorb water, it has excellent moisture permeability and can smoothly dissipate moisture into the outside air, so it can be used without inconveniences such as staining the affected area, and it also has good barrier properties against bacteria, etc. It can be protected. Furthermore, the coating has high flexibility and strength, does not adhere to the affected area due to body fluids, and can be easily removed without damaging the affected area when peeled off after use. Furthermore, when a drug is retained, the drug retention and release properties are good, and the composition of the present invention is easy to use and has good manufacturability. In this way, when actually applied, a nylon coating containing a water-absorbing polymer substance prevents external physical stimulation and the invasion of bacteria for a long period of time without staining the affected area, and also prevents exudable body fluids. It can be removed quickly and in large quantities from the affected area, promoting the formation of new tissue, and there is almost no damage to the affected area when peeled off after use, so it is effective against exudative skin diseases such as cuts and burns. It can be used effectively. EXAMPLES Hereinafter, the present invention will be specifically explained with reference to examples, but the present invention is not limited to the following examples. [Example 1] Soluble nylon (Ultraamide manufactured by BASF)
1C) 20% solution (solvent: ethanol/water 90/
10 weight ratio) 100g Water-absorbing polymer material (Aquarik manufactured by Nippon Shokubai Co., Ltd.)
CA) 2g carboxyvinyl polymer 0.3g A water-absorbing polymer substance and carboxyvinyl polymer were added to a soluble nylon solution, which was applied in the form of a sheet and dried to form a sheet with a thickness of 50μ. This sheet can be used by cutting it into an appropriate size and attaching it to a predetermined affected area with adhesive tape, or by applying an adhesive to the periphery of one side of the sheet and attaching it to the affected area. In addition, by wetting the affected area with alcohol and applying it, good adhesion can be achieved without using any adhesive. As is clear from the results of the experiments described below, the sheet with the above formulation has excellent water vapor permeability, body fluid absorption,
It had excellent bacterial barrier properties and peelability, as well as excellent flexibility and strength, making it suitable for protecting affected areas. [Example 2] Soluble nylon (Teikoku Kagaku Co., Ltd. Torezin F30)
20% solution of (solvent: ethanol/water 85/15 weight ratio) 20g 20% of soluble nylon (Ultraamide 1C)
Solution (solvent: ethanol/water 90/10 weight ratio)
80g Water-absorbing polymer material (gelatin-dialdehyde starch cross-linked product) 8g Water-absorbing polymer material (Aquarik CA) 2g Hydrophilic urethane prepolymer (manufactured by Lion Corporation)
UP-200) A 50μ sheet was molded from 1.5g or more of the ingredients in the same manner as in Example 1. In addition to the features of the sheet of Example 1, this sheet has
Furthermore, it was highly flexible and showed sufficient followability to the movements of joints, etc. [Example 3] Benzalkonium chloride 0.01g Chlorhexidine gluconate 0.01g Diphenhydramine 0.1g Naphazoline hydrochloride 0.1g 20% of soluble nylon (Ultraamide 1C)
Solution (solvent: ethanol/water 85/15 weight ratio)
100.0g Water-absorbing polymer material (Shazenshi) 10.0g Polyvinylpyrrolidone (K-90) 0.5g A 50μ sheet was molded from the above ingredients in the same manner as in Example 1. This material also has excellent antibacterial properties and is highly effective as a sheet for treating wounds and exudative skin injuries, and could be removed without damaging the wound. [Example 4] Sulfazine 1.0g Chlorhexidine gluconate 0.01g Allantoin 0.5g 20% of soluble nylon (Ultraamide 1C)
Solution (solvent: ethanol/water 85/15 weight ratio)
100.0g Water-absorbing polymer material (gelatin-dialdehyde starch crosslinked product) 15.0g A 50μ sheet was molded from the above ingredients in the same manner as in Example 1. This product is extremely effective for burns and ulcers with erosive surfaces, promotes epidermal formation, and can be smoothly removed without damaging new tissue even after use. In the above examples, the gelatin-dialdehyde starch crosslinked product was 10% of gelatin.
Add 1g of dialdehyde starch to 100g of aqueous solution,
A product obtained by drying and pulverizing a gel-like product subjected to a heating reaction was used. Next, the sheets obtained in the above examples were examined for their water vapor permeability, body fluid absorption, peel strength, germ barrier properties, and antibacterial properties using the following methods. Also, for comparison, soluble nylon (Ultraamide 1C)
These properties were also investigated for 50μ nylon sheets and gauze obtained using chisel. (1) Water vapor permeability Water vapor permeability in a cylindrical cup (made of glass) with a radius of 17 mm.
After putting 10g into the cup and sealing the mouth of the cup with sheets of various samples and leaving it in a constant temperature and humidity chamber at 37°C - 65% and 37°C - 42% for 24 hours, the water loss was measured and the value was calculated using 1m of the sheet. This was converted to 2 per cent and used as an index of water vapor permeability. (2) Body fluid absorption A 10cm x 10cm sheet was immersed in physiological saline for 5 minutes, taken out, sandwiched between pieces of paper to remove excess water, the amount of body fluid absorbed was measured, and this was converted to 1g of the sheet. , the amount of body fluid absorbed. (3) Peeling force Tobacco filter was created as a substitute body fluid37
The force when soaking the sample sheet in a 10% gelatin-1% polyvinylpyrrolidone solution at ℃ to fully swell it, immediately placing it on a sample sheet, drying it completely, and peeling it off at a speed of 2 cm/min using a tensilon meter. was used as an index of releasability. In order to prevent the sheet from stretching when it was peeled off, cellophane tape was attached to the back of the sheet at the time of measurement. (4) Bacterial barrier properties of the sheet Place the sheet on an agar plate (SCD for bacteria, GP for yeast). Place a paper disk (manufactured by Toyo Seisakusho Co., Ltd.) soaked in the test bacterial solution for 1 minute and leave it for 1 hour or 24 hours, then remove the disk and sheet and culture (bacteria at 37℃ for 24-48 hours; yeast at 27℃). , 6 days). After culturing, the presence or absence of growth of these bacteria is determined visually. Evaluation criteria +: Bacterial permeation -: Bacterial non-permeable (5) Antibacterial property of sheet Sterile agar medium heated to 50℃ (for bacteria, SCD,
Yeast (GP) was inoculated with the test bacteria solution at a ratio of 0.1 ml/100 ml of medium, mixed well, and then placed in a sterile petal for 15 minutes.
Dispense ~20ml and allow to solidify. Place the sheet on this plate and culture (conditions are the same as (4)). After culturing, the width of these inhibition zones is measured to determine antibacterial properties. Evaluation criteria −: No antibacterial property, width of inhibition zone 1 mm or less ±: Antibacterial property, 1 to 3 mm +: 3 to 5 mm: 5 mm or more In addition, in the experiments (4) and (5) above, The following bacteria were used as test bacteria. Bacteria Gram-positive bacteria Staphylococcus aureus (St 1 ) Gram-negative bacteria Escherichia coli (E-Coli) Pseudomonas aeruginosa (Ps) Yeast Candida (Ca) The above results are shown in Tables 1 to 3.
【表】【table】
【表】【table】
【表】
以上の結果より、実施例のシートはいづれも著
しく高い水蒸気透過性を示し、患部をむらすこと
が少ないと共に、体液吸収量も従来のガーゼの4
倍以上と多く、素早く浸出せる体液を効率よく患
部表面より排除し得るものであり、かつ剥離力も
小さく、使用後の除去に際して新生組織を傷つけ
ることが少ないものであり、また菌バリヤー性を
示して外気中の雑菌の侵入を防ぎ、更に殺菌剤配
合のものは抗菌性を示し、シートより徐々に薬物
が放出されて持続した薬効が得られることが認め
られた。[Table] From the above results, all of the sheets of the examples showed extremely high water vapor permeability, did not cause staining of the affected area, and the amount of body fluid absorbed was 4 times lower than that of conventional gauze.
It is more than twice as large and can efficiently remove rapidly exudable body fluids from the surface of the affected area. It also has a small peeling force, so it does not damage new tissue when removed after use, and it also shows bacteria barrier properties. It was found that the sheet prevents the invasion of germs from the outside air, and that the sheet containing a bactericide exhibits antibacterial properties, and that the drug is gradually released from the sheet, resulting in a sustained medicinal effect.
Claims (1)
的には水に不溶の吸水性高分子物質とを含有して
なることを特徴とする外皮用組成物。 2 ナイロン樹脂がアルコール可溶性ナイロンで
ある特許請求の範囲第1項記載の組成物。 3 吸水性高分子物質がゼラチン、寒天、シヤゼ
ンシ、ゼラチン架橋体、合成水溶性物質の架橋
体、グラフト重合によつて水溶性幹高分子物質に
他の高分子物質を導入したもの、又は親水セグメ
ントと疎水性セグメントを有する合成重合体であ
る特許請求の範囲第1項又は第2項記載の組成
物。 4 組成物がシート状の形態に形成されてなる特
許請求の範囲第1項乃至第3項いずれか記載の組
成物。[Scope of Claims] 1. A skin composition comprising a nylon resin and a water-absorbing polymeric substance that swells and disperses in water but is substantially insoluble in water. 2. The composition according to claim 1, wherein the nylon resin is alcohol-soluble nylon. 3 The water-absorbing polymeric substance is gelatin, agar, chazen, crosslinked gelatin, crosslinked synthetic water-soluble substance, a water-soluble main polymeric substance with another polymeric substance introduced by graft polymerization, or a hydrophilic segment. The composition according to claim 1 or 2, which is a synthetic polymer having a hydrophobic segment and a hydrophobic segment. 4. The composition according to any one of claims 1 to 3, wherein the composition is formed in a sheet form.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56167749A JPS5869811A (en) | 1981-10-20 | 1981-10-20 | Composition for application to cuticle |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56167749A JPS5869811A (en) | 1981-10-20 | 1981-10-20 | Composition for application to cuticle |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5869811A JPS5869811A (en) | 1983-04-26 |
JPS6346700B2 true JPS6346700B2 (en) | 1988-09-16 |
Family
ID=15855386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56167749A Granted JPS5869811A (en) | 1981-10-20 | 1981-10-20 | Composition for application to cuticle |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5869811A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11253040B2 (en) | 2020-04-10 | 2022-02-22 | Lg Electronics Inc. | Diffuser and hair dryer having a diffuser |
US11576474B2 (en) | 2020-04-10 | 2023-02-14 | Lg Electronics Inc. | Diffuser and hair dryer having the same |
TWI793465B (en) * | 2020-04-10 | 2023-02-21 | 南韓商Lg電子股份有限公司 | Diffuser and hair dryer having a diffuser |
US11589662B2 (en) | 2020-04-10 | 2023-02-28 | Lg Electronics Inc. | Hair dryer |
US11633028B2 (en) | 2020-04-10 | 2023-04-25 | Lg Electronics Inc. | Diffuser and hair dryer having a diffuser |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3257905B2 (en) * | 1994-07-29 | 2002-02-18 | 一丸ファルコス株式会社 | Skin sticking sheet |
US6144500A (en) * | 1997-03-05 | 2000-11-07 | Asahi Kogaku Kogyo Kabushiki Kaisha | Plastic lens |
JP2002228909A (en) * | 2001-02-06 | 2002-08-14 | Konica Corp | Optical unit |
-
1981
- 1981-10-20 JP JP56167749A patent/JPS5869811A/en active Granted
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11253040B2 (en) | 2020-04-10 | 2022-02-22 | Lg Electronics Inc. | Diffuser and hair dryer having a diffuser |
US11576474B2 (en) | 2020-04-10 | 2023-02-14 | Lg Electronics Inc. | Diffuser and hair dryer having the same |
TWI793465B (en) * | 2020-04-10 | 2023-02-21 | 南韓商Lg電子股份有限公司 | Diffuser and hair dryer having a diffuser |
US11589662B2 (en) | 2020-04-10 | 2023-02-28 | Lg Electronics Inc. | Hair dryer |
US11633028B2 (en) | 2020-04-10 | 2023-04-25 | Lg Electronics Inc. | Diffuser and hair dryer having a diffuser |
US11647822B2 (en) | 2020-04-10 | 2023-05-16 | Lg Electronics Inc. | Diffuser and hair dryer having a diffuser |
Also Published As
Publication number | Publication date |
---|---|
JPS5869811A (en) | 1983-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3328259A (en) | Dressing for a wound containing a hemostatic agent and method of treating a wound | |
US4759354A (en) | Wound dressing | |
EP1781098B1 (en) | Antimicrobial devices and compositions | |
US7576255B2 (en) | Silver-containing compositions, devices, and methods for making | |
JP2559225B2 (en) | Antiseptic liquid | |
US5064653A (en) | Hydrophilic foam compositions | |
EP2582404B1 (en) | Antimicrobial silicone-based wound dressings | |
EP1216065B1 (en) | Silver-containing compositions, devices and methods for making | |
JP2002523565A (en) | Naturally antibacterial quaternary amine hydrogel wound dressing | |
JPS62266063A (en) | Antibacterial bandage or drape for incision | |
JPH0790039B2 (en) | Method for producing infection-resistant composition | |
KR20160067120A (en) | Non-self-adherent coating materials | |
EP2217290A2 (en) | Silicone hydrogels for tissue adhesives and tissue dressing applications | |
JP2022523780A (en) | Antibacterial dressings, dressing components, and methods | |
US20140249496A1 (en) | Compositions for use as or in wound dressings | |
US20210178009A1 (en) | Wound care products comprising alexidine | |
AU2003243262A1 (en) | Hydrophilic foam compositions having antimicrobial properties | |
JP6290184B2 (en) | Wound dressing | |
US20060062854A1 (en) | Hydrogel having anti-microbial properties | |
JPS6346700B2 (en) | ||
CA2018007A1 (en) | Treating skin and lesions | |
EP2780005A1 (en) | Controlled release of active using ph | |
Sone et al. | Sericin biofilm endowed with silver sulfadiazine for treatment of burns | |
RU2284824C1 (en) | Surgical antiseptic glue "argacol" | |
CN117136081A (en) | Wound care products including antimicrobial coatings |